Hemostasis & Tissue Sealing Agents Market in United Kingdom, United States

1. Executive Summary: Hemostasis & Tissue Sealing Agents
   • Global Market Outlook: Hemostasis & Tissue Sealing Agents
2. Competitive Intelligence Analysis: Hemostasis & Tissue Sealing Agents
3. Therapeutic Sector SWOT
4. Technology Roadmap Analysis: Hemostasis & Tissue Sealing Agents
5. Market Background
   • Drivers
   • Restraints
   • Opportunity
   • Key Market Trends
   • Key Unmet Needs
6. Key Marketed Products Profile – Major Approved Products: Hemostasis & Tissue Sealing Agents
   • Product Profile
   • Safety and Efficacy
7. Regulatory Landscape
8. Hemostasis & Tissue Sealing Agents: Ten Major Market (10MM) – Market Analysis, By Product
   • Topical Hemostats
     • Mechanical Hemostats
     • Active Hemostats
     • Flowable Hemostats
   • Tissue Sealing Agents
     • Fibrin Sealants
     • Synthetic Sealants
   • Adhesives
     • Cyanoacrylate
     • Albumin and Glutaraldehyde

9. Hemostasis & Tissue Sealing Agents: Ten Major Market (10MM) – Market Analysis, By Material
   • Gelatin-based Topical Hemostats
   • ORC-based Topical Hemostats
   • Polysaccharide based Topical Hemostats
   • Collagen-based Topical Hemostats
10. Hemostasis & Tissue Sealing Agents: Ten Major Market (10MM) – Market Analysis, By Application
    • General Surgery
    • Trauma
    • Hemophilia
    • Minimally Invasive Surgery
    • Other Applications
11. Hemostasis & Tissue Sealing Agents: Ten Major Market (10MM) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Material
      • By Application
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Material
      • By Application

12. S. Hemostasis & Tissue Sealing Agents – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Material
      • By Application
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Material
      • By Application

13. K. Hemostasis & Tissue Sealing Agents – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Material
      • By Application
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Material
      • By Application

14. Germany Hemostasis & Tissue Sealing Agents – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Material
      • By Application
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Material
      • By Application

15. France Hemostasis & Tissue Sealing Agents – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Material
      • By Application
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Material
      • By Application

16. Italy Hemostasis & Tissue Sealing Agents – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Material
      • By Application
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Material
      • By Application

17. Spain Hemostasis & Tissue Sealing Agents – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Material
      • By Application
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Material
      • By Application

18. Japan Hemostasis & Tissue Sealing Agents – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Material
      • By Application
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Material
      • By Application

19. China Hemostasis & Tissue Sealing Agents – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Material
      • By Application
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Material
      • By Application

20. Australia Hemostasis & Tissue Sealing Agents – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Material
      • By Application
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Material
      • By Application

21. India Hemostasis & Tissue Sealing Agents – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product
      • By Material
      • By Application
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product
      • By Material
      • By Application

22. Competitive Landscape
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Sales Footprint

Note – All Major Company Profiles (Count up to 20) will be covered in the report

23. Assumptions and Acronyms Used
24. Research Methodology
    • Secondary Research
    • Primary Research
    • Data Triangulation
25. Geographic Scope
    • The U.S., The U.K., Germany, France, Italy, Spain, Japan, China, Australia, and India
26. Copyrights and Disclaimer

Hemostasis & Tissue Sealing Agents Market – Report Overview

Pacific Business Consulting’s “Hemostasis & Tissue Sealing Agents Market in United Kingdom ” – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)” report offers a comprehensive understanding of Hemostasis & Tissue Sealing Agents market, encompassing historical and projected market size data, along with market trends, market drivers, market barriers and unmet medical needs in the Ten Major Markets of the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, China, Australia, and India.

In 2022, the Hemostasis & Tissue Sealing Agents market exceeded a valuation of over US$ 4.5 Billion, and it is poised for substantial growth, with a projected Compound Annual Growth Rate (CAGR) exceeding 6.0% from 2023 to 2030. The market is expected to potentially surpass US$ 6.5 Billion by 2030.

Hemostasis and tissue sealing agents are utilized to halt bleeding during surgical procedures and trauma. Two primary categories of products are prevalent in the market: mechanical and biological. Mechanical agents function by adhering to the tissue and sealing the wound physically to prevent blood loss. While they provide rapid hemostasis, they are not absorbed by the body over time. Common mechanical agents include surgical staplers, wound closure strips, and sutures.

The growth of the hemostasis and tissue sealing agents market in Japan is anticipated to be significantly influenced by factors such as the increasing number of surgical procedures and the rising incidence of road accidents. Notably, a study published in the International Journal of Surgery in September 2020 revealed that more than 300 million major surgeries occur globally each year, with 40 to 50 million in the United States and 20 million in Europe. Such trends are poised to boost the adoption of hemostasis and tissue-sealing agents, contributing to market growth in Germany.

The market in China is further driven by the escalating prevalence of chronic blood disorders. According to the International Society on Thrombosis and Hemostasis, approximately 10 million cases of venous thromboembolism occur worldwide annually. In Europe, there are 544,000 Deep Vein Thrombosis (DVT)-related deaths each year. Additionally, over 3.2 million Americans are living with bleeding disorders annually, as reported in the Disorders of the Blood 2022 report by PhRMA in May 2022. The increasing number of patients with blood disorders and the need to address various bleeding conditions are expected to fuel the demand for hemostasis and tissue-sealing agents.

The market in France is also stimulated by the rising prevalence of diseases requiring surgical interventions. Cardiovascular diseases and cancer, which are leading global causes of death, often necessitate surgeries involving substantial blood loss. Hemostats and sealants play a crucial role in controlling bleeding during surgeries for conditions such as lung cancer, breast cancer, prostate cancer, and colorectal surgery.

Technological advancements are significant drivers of market growth. Advances in medical technology have led to the development of newer methods and products for achieving hemostasis during surgery. Notable technological developments include advanced energy devices for minimally invasive surgery, robot-assisted surgery platforms, and next-generation hemostatic products. Fibrin sealants, replacing sutures or staples for incision sealing, are gaining higher adoption rates, particularly in cardiovascular and neurosurgeries.

As medical technology continues to advance, minimally invasive surgical procedures are becoming more prevalent, reducing recovery times and trauma. Hemostasis and tissue sealing agents play a vital role in these procedures by controlling bleeding and reinforcing sutures or staple lines laparoscopically. Growing awareness among physicians and patients regarding the benefits of these tools in orthopedic, cardiovascular, and neurological interventions is driving substantial demand.

The hemostasis and tissue sealing agents market is expected to experience steady growth due to the increasing number of surgical procedures worldwide. The growing geriatric population, which is more susceptible to chronic diseases, will positively influence the demand for effective hemostats and sealants.

Leading players in the Hemostasis & Tissue Sealing Agents segment, including Ethicon (Johnson & Johnson), Baxter International, CryoLife, B. Braun Melsungen AG, Covidien (now Medtronic), Integra LifeSciences, Pfizer, Teleflex, Arch Therapeutics, and Becton, Dickinson & Company, are expected to play a crucial role in shaping the future landscape of Hemostasis & Tissue Sealing Agents technologies through ongoing innovation.

Scope of Report

The report addresses critical subjects such as strategic competitor evaluation, market characterization, unmet needs, and the consequences of these elements for the Hemostasis & Tissue Sealing Agents market. It also delves into the analysis of present and prospective market competition within the global Hemostasis & Tissue Sealing Agents market in Australia.

Furthermore, the report offers an insightful examination of the primary industry drivers, constraints, and challenges. Each trend undergoes independent research to furnish qualitative analysis regarding its implications.

Reasons to Buy

• Develop your business strategies by gaining insights into the trends that shape and drive the Hemostasis & Tissue Sealing Agents market across the Italy.
• Increase revenue by comprehending key trends, innovative products and technologies, market segments, and companies poised to influence the future of the 10MM Hemostasis & Tissue Sealing Agents market.
• Craft effective sales and marketing strategies by thoroughly understanding the competitive landscape and analyzing the performance of various competitors.
• Identify emerging players with potentially robust product portfolios and devise strategic counter-strategies to gain a competitive advantage.
• Optimize your sales and marketing efforts by pinpointing market categories and segments that offer the greatest opportunities for consolidations, investments, and strategic partnerships.